PT-141 10mg

PT‑141 — Overview

PT‑141 (Bremelanotide) is a synthetic heptapeptide derived from the melanocortin peptide family. It is commonly used in research exploring melanocortin receptor pathways, neurological signaling, and peptide–receptor interactions. Unlike many peptides studied for peripheral biochemical activity, PT‑141 is frequently examined for its effects on central nervous system signaling, particularly through the MC3R and MC4R receptors.

Background & Research Interest

PT‑141 is often studied in laboratory environments focused on:

• Melanocortin receptor activation (MC3R / MC4R)
• Neuropeptide‑driven signaling pathways
• Structure–activity relationships within melanocortin analogs
• Central nervous system regulatory mechanisms
• Peptide stability and receptor selectivity

Its unique receptor profile makes it a valuable model for studying melanocortin‑related biochemical processes.

General Characteristics

• Peptide Type: Synthetic melanocortin analog
• Sequence: Ac‑Nle‑Asp‑His‑D‑Phe‑Arg‑Trp‑Lys‑OH
• Receptor Targets: Primarily MC3R and MC4R
• Form: Typically supplied as a lyophilized powder
• Solubility: Commonly reconstituted in sterile, research‑grade solvents
• Purity: Usually provided at high purity suitable for controlled laboratory research

Storage & Handling

• Store in a cool, dry environment, protected from light
• Keep vial sealed until use
• Handle using standard laboratory safety procedures

For laboratory research only. Not for human consumption.

I